4Kathryn V. SARS coronavirus., a new challenge for prevention and therapy[J]. J Clin Invest, 2003, 111 (11):1605-1609.
5Mezarina KB, Huffmire A, Downing J, et al. Outbreak of community-acquired pnrumonia caused by mycoplasma pneumoniae-coloado 2000, [J], JAMA, 2001,50 (4) : 227-230.
6Petitjean J, Vabret A, Gouarin S, et al. Evaluation of four commercial immunoglobulin G(IgG) and IgM-specific enzyme immunoassays for diagnosis of mycoplasma pneumoniae infections[J]. J Clin Microbiol, 2002,40 (1) : 165-171.
7Kong FR, Susanna G, Gwendolyn LG. Rapid cycle PCR for detection and typing of mycoplasma pneumoniae in clinical specimens [J]. J Clin Microbiol, 2000, 38 ( 11 ) :4256-4259.
8Junichi H,Takafumi Y, Mikako K, et al. Clinical use of capillary PCR to diagnose mycoplasma pneumonia[J]. J Clin Microbiol, 2000,38 (4) : 1382-1384.
9Marianne AH,Ulrich B, Hans N, et al. Molecular approaches to diagnosis of pulmonary disease due to mycoplasma pneumoniae[J]. J Clin Microbiol, 1998,36 (2) : 548-551.
10Blasi F, Tarsia P, Arosio C, et al. Epidemiology of chlamydia pneumoniae[J]. Clin Microbiol Infect, 1998,4(Suppl 4):S1-S6.
